A widely available antidepressant may provide meaningful relief for people experiencing persistent fatigue from long COVID, according to a global clinical trial co-led by McMaster University.
Researchers found that fluvoxamine (sold under the…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply